S'abonner

Presentation of Celiac Disease in Finnish Children Is No Longer Changing: A 50-Year Perspective - 24/10/15

Doi : 10.1016/j.jpeds.2015.07.057 
Laura Kivelä, BM 1, Katri Kaukinen, MD, PhD 2, Marja-Leena Lähdeaho, MD, PhD 1, Heini Huhtala, MSc 3, Merja Ashorn, MD, PhD 4, Tarja Ruuska, MD, PhD 5, Pauliina Hiltunen, MD, PhD 1, Jarmo Visakorpi, MD, PhD 1, Markku Mäki, MD, PhD 1, Kalle Kurppa, MD, PhD 1,
1 Tampere Center for Child Health Research, University of Tampere and Tampere University Hospital, Tampere, Finland 
2 Department of Internal Medicine, Tampere University Hospital and School of Medicine, University of Tampere, Tampere, Finland 
3 Tampere School of Health Sciences, University of Tampere, Tampere, Finland 
4 Department of Pediatrics, Lappeenranta Central Hospital, Lappeenranta, Finland 
5 Department of Pediatrics, Tampere University Hospital, Tampere, Finland 

Reprint requests: Kalle Kurppa, MD, PhD, Tampere Center for Child Health Research, University of Tampere and Tampere University Hospital, Biokatu 10, 33520 Tampere, Finland.

Abstract

Objectives

To chart trends in the presentation of celiac disease in a large cohort of Finnish children diagnosed over a period of 48 years.

Study design

Clinical and serologic data, severity of small-bowel mucosal damage, and presence of associated conditions were gathered from 596 children diagnosed with celiac disease in 1966-2013. The children were divided into 4 groups based on the year of diagnosis (before 1980, 1980-1999, 2000-2009, and 2010-2013), and the variables were compared between the periods. The incidence of celiac disease autoimmunity in 2001-2013 was calculated based on the number of new antibody-positive cases in each year.

Results

Age at diagnosis rose from median 4.3 years before 1980 to between 7.6 and 9.0 years in the later periods. The severity of clinical presentation, in general, became milder and poor growth less common during the entire study period of 50 years. Percentages of children with classical gastrointestinal presentation decreased, and those with atypical or subclinical presentation increased after the 1990s, these changes leveling off in 2000-2013. Similarly, the severity of small-bowel mucosal damage was milder after the 1990s. The incidence of celiac disease autoimmunity increased in the early 2000s but then fluctuated without a clear trend. There were no significant secular changes in sex distribution, presence of anemia, levels of celiac antibodies, or celiac disease-associated conditions.

Conclusions

The clinical and histologic presentation of celiac disease in children became milder, especially in the 1980s and 1990s. However, most of these changes have reached a plateau in recent years.

Le texte complet de cet article est disponible en PDF.

Keyword : CDA, EmA, PVA, SVA, TG2ab, TVA


Plan


 Supported by the Academy of Finland Research Council for Health, the Competitive State Research Financing of the Expert Responsibility Areas of Tampere University Hospital (9P060, 9R018, 9R034), the Mary and Georg Ehrnrooth Foundation, the Sigrid Juselius Foundation, and the Foundation for Pediatric Research and the Finnish Medical Foundation. The authors declare no conflicts of interest.


© 2015  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 167 - N° 5

P. 1109 - novembre 2015 Retour au numéro
Article précédent Article précédent
  • Annual Costs of Care for Pediatric Irritable Bowel Syndrome, Functional Abdominal Pain, and Functional Abdominal Pain Syndrome
  • Daniël R. Hoekman, Juliette M.T.M. Rutten, Arine M. Vlieger, Marc A. Benninga, Marcel G.W. Dijkgraaf
| Article suivant Article suivant
  • Medial Epicondyle Fractures in Children and Adolescents: Shifting Care from General Hospitals to Children's Hospitals?
  • Peter D. Fabricant, Mark A. Seeley, Jason B. Anari, Theodore J. Ganley, John M. Flynn, Keith D. Baldwin

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.